Why is Medico Remedies Ltd falling/rising?

Recent Price Performance and Market Context

Medico Remedies has experienced a sustained downward trend over the past week, with a one-week return of -5.56%, significantly lagging behind the Sensex’s modest decline of -0.99% during the same period. Over the last month, the stock has fallen by 2.70%, again underperforming the Sensex’s 1.20% drop. The year-to-date figures further highlight the stock’s struggles, showing a negative return of 6.76%, contrasting sharply with the Sensex’s robust 8.36% gain. This underperformance extends to longer time horizons as well, with the stock down 8.95% over the past year and 22.38% over three years, while the Sensex has delivered positive returns of 8.21% and 39.17% respectively.

Despite this recent weakness, it is important to note that Medico Remedies has delivered exceptional long-term gains, with a five-year return exceeding 1250%, vastly outperforming the Sensex’s 77.34% over the same period. This suggests that while the stock is currently facing headwinds, its historical performance remains impressive.

Intraday Trading Dynamics and Technical Indicators

On 30-Dec, the stock touched an intraday low of ₹50.75, marking a 3.5% decline for the day. The weighted average price indicates that a greater volume of shares traded near this lower price point, signalling selling pressure. From a technical standpoint, the stock price remains above its 100-day and 200-day moving averages, which often act as long-term support levels. However, it is trading below its short-term moving averages of 5-day, 20-day, and 50-day, suggesting near-term weakness and a bearish trend in the short run.

Investor Participation and Liquidity Concerns

One of the key factors contributing to the stock’s decline appears to be a sharp drop in investor participation. Delivery volume on 29-Dec was recorded at 64.82 lakh shares, which represents a steep 70.68% decrease compared to the five-day average delivery volume. This significant reduction in investor engagement may indicate waning confidence or a cautious stance among shareholders, exacerbating the downward price movement.

Despite this, liquidity remains adequate for trading, with the stock’s average traded value supporting trade sizes of approximately ₹0.03 crore based on 2% of the five-day average traded value. This level of liquidity ensures that the stock remains accessible to investors, although the reduced delivery volumes suggest less conviction in recent buying activity.

Summary and Outlook

Medico Remedies Ltd’s recent share price decline is primarily driven by a combination of technical weakness and diminished investor participation. The stock’s underperformance relative to the Sensex and its sector over multiple time frames highlights ongoing challenges. The three-day consecutive fall, resulting in a cumulative loss of 6.26%, underscores the current bearish sentiment among traders and investors.

While the stock remains above its longer-term moving averages, the short-term technical indicators suggest continued pressure. The sharp drop in delivery volumes further signals reduced buying interest, which may prolong the downward trend unless renewed investor confidence emerges.

Investors should monitor upcoming trading sessions closely to assess whether the stock can stabilise above key support levels or if the current negative momentum will persist. Given the stock’s strong historical performance, any recovery could present attractive opportunities, but caution is warranted in the near term.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →